Matrix Capital Management Company, LP Zentalis Pharmaceuticals, Inc. Put Options Transaction History
Matrix Capital Management Company, LP
- $63.9 Million
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ZNTL
# of Institutions
109Shares Held
58MCall Options Held
0Put Options Held
43.4K-
Black Rock Inc. New York, NY4.82MShares$6.41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$3.86 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.85MShares$3.78 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.33MShares$3.09 Million0.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC2.1MShares$2.79 Million23.31% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $75.8M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...